BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 21735432)

  • 1. Intratympanic steroids for Ménière's disease or syndrome.
    Phillips JS; Westerberg B
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008514. PubMed ID: 21735432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic gentamicin for Ménière's disease or syndrome.
    Pullens B; van Benthem PP
    Cochrane Database Syst Rev; 2011 Mar; (3):CD008234. PubMed ID: 21412917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic corticosteroids for Ménière's disease.
    Webster KE; Lee A; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Westerberg B; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015245. PubMed ID: 36847608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive pressure therapy for Ménière's disease or syndrome.
    van Sonsbeek S; Pullens B; van Benthem PP
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD008419. PubMed ID: 25756795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic gentamicin for Ménière's disease.
    Webster KE; Galbraith K; Lee A; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015246. PubMed ID: 36847592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery for Ménière's disease.
    Pullens B; Giard JL; Verschuur HP; van Benthem PP
    Cochrane Database Syst Rev; 2010 Jan; (1):CD005395. PubMed ID: 20091573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic therapy in Meniere's syndrome or disease: up to date evidence for clinical practice.
    Syed MI; Ilan O; Nassar J; Rutka JA
    Clin Otolaryngol; 2015 Dec; 40(6):682-90. PubMed ID: 25916787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical interventions for Ménière's disease.
    Lee A; Webster KE; George B; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015249. PubMed ID: 36825750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery for Ménière's disease.
    Pullens B; Verschuur HP; van Benthem PP
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD005395. PubMed ID: 23450562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of vertigo in Ménière's disease by intratympanic dexamethasone.
    Weckel A; Marx M; Esteve-Fraysse MJ
    Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Feb; 135(1):7-10. PubMed ID: 28760618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive pressure therapy for Meniere's syndrome/disease with a Meniett device: a systematic review of randomised controlled trials.
    Syed MI; Rutka JA; Hendry J; Browning GG
    Clin Otolaryngol; 2015 Jun; 40(3):197-207. PubMed ID: 25346252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.
    Lee SY; Kim YS; Jeong B; Carandang M; Koo JW; Oh SH; Lee JH
    Am J Otolaryngol; 2021; 42(6):103086. PubMed ID: 34098455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic pharmacological interventions for Ménière's disease.
    Webster KE; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015171. PubMed ID: 36827524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratympanic Sustained-Exposure Dexamethasone Thermosensitive Gel for Symptoms of Ménière's Disease: Randomized Phase 2b Safety and Efficacy Trial.
    Lambert PR; Carey J; Mikulec AA; LeBel C;
    Otol Neurotol; 2016 Dec; 37(10):1669-1676. PubMed ID: 27749754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle and dietary interventions for Ménière's disease.
    Webster KE; George B; Lee A; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Murdin L; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015244. PubMed ID: 36848645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive pressure therapy for Ménière's disease.
    Webster KE; George B; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015248. PubMed ID: 36815713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of vertigo after intratympanic corticoid therapy for unilateral Ménière's disease: a comparison of weekly versus daily fixed protocols.
    Martin Sanz E; Zschaeck C; Gonzalez M; Mato T; Rodrigañez L; Barona R; Sanz R
    Otol Neurotol; 2013 Oct; 34(8):1429-33. PubMed ID: 23722456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome.
    Hussain K; Murdin L; Schilder AG
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012173. PubMed ID: 30596397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diuretics for Ménière's disease or syndrome.
    Thirlwall AS; Kundu S
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD003599. PubMed ID: 16856015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.